Macular oedema

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
S Ophthalmology/ENT (ATC S) 1
Mechanism of action (INN-stem analysis)
Monoclonal antibody 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • Samsung Bioepis Co. Ltd. Commercial
    RANIBIZUMAB
    2025-520599-24-00 1 country 2026 n=30
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Samsung Bioepis Co. Ltd. Commercial 1 Phase II 0
New trials by year
2026
1
← All indication landscapes